Warren M. Kati
Infectious Diseases Research
Abbott Laboratories
Illinois 60064
USA
Name/email consistency: high
- In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replication. Kati, W.M., Montgomery, D., Carrick, R., Gubareva, L., Maring, C., McDaniel, K., Steffy, K., Molla, A., Hayden, F., Kempf, D., Kohlbrenner, W. Antimicrob. Agents Chemother. (2002)
- Novel alpha- and beta-amino acid inhibitors of influenza virus neuraminidase. Kati, W.M., Montgomery, D., Maring, C., Stoll, V.S., Giranda, V., Chen, X., Laver, W.G., Kohlbrenner, W., Norbeck, D.W. Antimicrob. Agents Chemother. (2001)
- Inhibition of 3C protease from human rhinovirus strain 1B by peptidyl bromomethylketonehydrazides. Kati, W.M., Sham, H.L., McCall, J.O., Montgomery, D.A., Wang, G.T., Rosenbrook, W., Miesbauer, L., Buko, A., Norbeck, D.W. Arch. Biochem. Biophys. (1999)
- GS4071 is a slow-binding inhibitor of influenza neuraminidase from both A and B strains. Kati, W.M., Saldivar, A.S., Mohamadi, F., Sham, H.L., Laver, W.G., Kohlbrenner, W.E. Biochem. Biophys. Res. Commun. (1998)









